Streetbeat News

Partnerships

AMPG

AmpliTech Group, Inc (NASDAQ:AMPG) has announced new partnerships and an increase in bookings within its Satcom components subdivision, Specialty Microwave. The division has booked $1 million in Q2 and Q3 of 2023, expected to convert to revenue mostly in the first half of 2024. This is attributed to securing business from global entertainment companies such as Warner Bros., Disney, Paramount, and CBS Viacom. The bookings are for assemblies crucial for efficient signal transmission and reception across news, TV, and entertainment networks.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:11 pm

CLSD

Clearside Biomedical announced that its partner, Arctic Vision, has completed enrollment in a Phase 3 clinical trial in China for XIPERE, a treatment for Uveitic Macular Edema. This marks a significant advancement of XIPERE in the Asia-Pacific region.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:10 pm

CART

Instacart (NASDAQ:CART) and Mount Sinai Solutions have announced a partnership to provide grocery stipends for post-operative and post-partum patients insured by a Mount Sinai Solutions health plan. The program aims to ease access to fresh groceries and household essentials after major life events. Patients within the Mount Sinai Solutions network will receive $110 in Fresh Funds for care episode to pay for delivery of groceries and essentials. The partnership also includes a tailored Mount Sinai Virtual Storefront for easy shopping and delivery of provider-recommended goods via Instacart.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:09 pm

VVOS

Vivos Therapeutics has entered into strategic agreements with Ormco and On Demand Orthodontist to supply Spark Clear Aligners to its national network of providers. This has led to an increase in Vivos' share price.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:01 pm

PLTR

Palantir Technologies Inc (NYSE:PLTR) shares are trading higher following reports that the company is close to securing a five-year contract with the UK's National Health Service worth up to $579 million. The deal, which could be extended for two additional years, is awaiting final approval. Palantir also announced a collaboration with PwC to help clients realize the value of data and AI-enabled operations.

Portfolio Pulse from Adam Eckert

October 04, 2023 | 12:49 pm

SNY

TEVA

Sanofi SA (SNY) and Teva Pharmaceutical Industries Ltd (TEVA) have announced a collaboration to co-develop and co-commercialize asset TEV ‘574, a drug currently in Phase 2b clinical trials for ulcerative colitis and Crohn's disease. Under the agreement, Teva will receive an upfront payment of $500 million and up to $1 billion in development and launch milestones. Both companies will share development costs and net profits and losses. Initial program results are expected in 2024, with Phase 3 trials beginning in 2025.

Portfolio Pulse from Vandana Singh

October 04, 2023 | 12:47 pm

FRLN

IKT

PLTR

Freeline reported positive initial clinical data from the first cohort of its Phase 1/2 GALILEO-1 trial of FLT201, a novel gene therapy candidate for Gaucher Disease. Inhibikase Therapeutics received FDA Orphan Drug Designation for Risvodetinib for the treatment of Multiple System Atrophy. Palantir Technologies collaborated with PwC to accelerate operational transformation.

Portfolio Pulse from ryanfaloona@benzinga.com

October 04, 2023 | 12:43 pm

INOD

Innodata Inc. (NASDAQ:INOD) is set to announce three AI/LLM engagements with leading information companies. The deals span legal and healthcare domains and range from strategy to implementation. In one engagement, Innodata will help a company create a strategic roadmap for AI/LLM integration for its products and internal operations. In another, Innodata will fine-tune LLMs for three customer use cases pertaining to legal services. In the third deal, Innodata will create medical golden datasets to train an LLM to support patient interactions.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 12:37 pm

ARCT

Arcturus Therapeutics' joint venture mRNA manufacturing partner, ARCALIS, has been awarded manufacturing grants by the Japanese government. To date, $165M has been awarded.

Portfolio Pulse from Bill Haddad

October 04, 2023 | 12:34 pm

PLTR

Palantir Technologies has announced a collaboration with PwC to accelerate operational transformation. This news has led to an increase in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 12:34 pm